Compare Amylx Pharmaceuticals Inc (AMLX) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Nucor Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Nucor Corporation trades at $271.95 (market cap $61.93B). The key difference: Nucor Corporation is far larger — about 23.5× Amylx Pharmaceuticals Inc's market cap, and Nucor Corporation pays a 0.82% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | NUE | |
|---|---|---|
Market Cap | $2.64B | $61.93B |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $274.74 |
52-Week Low | $7.82 | $131.78 |
Enterprise Value | $2.39B | $66.34B |
Dividend Yield | — | 0.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
